• newly diagnosed1
• relapsed/refractory5

• Protocols

• ANBL2131

  OPEN TO ACCRUAL

  Ph3 HR Neuroblastoma with Dinutuximab and Multimodal Therapy
  
  

• PEDCITN02

  OPEN TO ACCRUAL

  Ph1 GD2 targeted Modified T cells for Children and AYA with NBL and Osteosarcoma